Survodutide
What Is Survodutide?
Survodutide Dragon Pharma is a 10 mg vial of lyophilized peptide, also known as BI 456906. It is a dual agonist at the glucagon receptor and the GLP-1 receptor, designed so that the two signals balance each other: GLP-1 handles appetite and gastric emptying, glucagon adds energy expenditure and fat oxidation. The molecule is in late stage trials for obesity and for metabolic liver disease.
Published pharmacokinetics put the half-life near six days, which supports the once-weekly schedule and explains why a missed injection is not an emergency but a dose increase is: the drug is still on board from the week before when the next step lands.
Survodutide Dosage
Trial protocols start at 0.3 mg weekly and step up every four weeks through 0.6, 1.2, 2.4 and 3.6 mg, with some arms reaching 6 mg. The steps exist because gastrointestinal tolerance builds slowly. Injection is subcutaneous, once weekly, and the site should rotate between abdomen, thigh and upper arm.
| Level | Dose | Units | Cycle | Note |
|---|---|---|---|---|
| Start | 0.3 mg/week | 3 units at 1 mg/mL | 4 weeks | tolerance only |
| Standard | 2.4 mg/week | 24 units at 1 mg/mL | 12 weeks | mid trial dose |
| High | 3.6-6 mg/week | 36-60 units at 1 mg/mL | 12-16 weeks | trial maximum range |
Cycle Length
Twelve to sixteen weeks is the shortest block that shows a clear trend in weight and waist measurement, and the trial data runs much longer. Because the half-life is about six days, steady state is reached after four to five weeks at a given dose, so a two week trial of a dose tells you very little about how it will feel at week six.
Survodutide Stacks
Survodutide is not combined with another incretin agonist. The table below shows the items that are used around it, and what each one is there for.
| Partner | Role | Effect |
|---|---|---|
| Mazdutide 10 mg | Similar receptor profile | an alternative for a later block, not a same-week partner |
| Cagrilintide | Amylin analogue | researched separately for satiety |
| BPC-157 | Gut support | reported for the digestive load of incretins |
| Weight loss category | Cycle context | orals and other agents in the same category |
Where survodutide differs from Semaglutide is the glucagon arm: more energy expenditure, more heart rate, and in trial data a larger effect on liver fat. Where it matches is the gastrointestinal profile, which is the part most users underestimate.
Survodutide Side Effects
Nausea, vomiting, diarrhoea and constipation are the standard set, with intensity peaking after each dose increase. Heart rate climbs by a few beats per minute. Appetite can fall far enough that hitting a protein target becomes the main challenge of the block.
- Nausea and vomiting, strongest in the days after a dose step
- Constipation or diarrhoea, sometimes alternating week to week
- Reflux and a feeling of early fullness
- Raised resting heart rate and occasional palpitations
- Loss of lean body mass if protein and training are not maintained
Gallbladder problems are reported across the incretin class, and rapid weight loss is a known risk factor on its own. A slow ramp and a sensible rate of loss reduce that risk more than any supplement.
Support and Supplies
Reconstitution equipment first, then the pharmacy items that make the first weeks manageable.
- Bacteriostatic water for a 10 mg vial, 2 ml gives 5 mg per ml
- BD syringes for accurate small volumes
- Peptide calculator for unit conversion
- Motilium 10 mg for nausea during titration
- Protonix 40 mg for reflux and gastric irritation
- Amaryl 1 mg only under medical supervision if glucose is being managed
Store the dry vial at room temperature and the reconstituted one in the fridge, and never freeze a solution that has already been mixed. The peptides and steroids primer explains why a compound like this one has no PCT phase.
Where to Buy Survodutide
Stock and shipping come from Steroid Warehouse, with the USD price on the product card.
Survodutide ships as one 10 mg vial from Dragon Pharma. Inspect the powder before reconstitution: a solid plug is normal, while discoloured or shrunken powder that has pulled away from the wall suggests heat exposure in transit.
This information is for educational purposes only. These products are not approved medicines in most countries, human safety data is limited, and self-administration carries risk. Speak to a physician before use.
All products from this manufacturer are listed together in the Dragon Pharma range.
What is Survodutide?
Survodutide is a dual GLP-1/glucagon agonist peptide for weight loss; see What is Survodutide. It enhances fat loss; for safe use.
How does Survodutide work?
It activates GLP-1 and glucagon receptors to reduce appetite and boost fat loss; It delivers significant weight loss-monitor with labs.
Is Survodutide safe?
It's safe with proper dosing and monitoring, but investigational; see Side Effects for safety due to Phase II status.
What is Survodutide used for?
It's used for weight loss, glucose control, and metabolic health; see Key Benefits. It suits fitness goals-use with professional oversight.
When to take Survodutide?
Inject 0.6-4.8 mg weekly, titrating up; Use with diet and monitoring-consult for tailored plans.
How long does it take to notice effects from Survodutide?
Many users report gradual reductions in appetite and improvements in satiety within the first few weeks, while body composition changes typically develop over a longer period.
What are the main benefits of Survodutide?
Commonly discussed benefits include appetite suppression, enhanced satiety, support for weight loss, improved metabolic health, and assistance with body composition goals.
What are the possible side effects of Survodutide?
Potential side effects may include nausea, vomiting, diarrhea, constipation, bloating, and other gastrointestinal effects commonly associated with incretin-based peptides.